- HER2, TOP2A, and TIMP-1 and responsiveness to adjuvant anthracycline-containing chemotherapy in high-risk breast cancer patients. Ejlertsen, B., Jensen, M.B., Nielsen, K.V., Balslev, E., Rasmussen, B.B., Willemoe, G.L., Hertel, P.B., Knoop, A.S., Mouridsen, H.T., Brünner, N. J. Clin. Oncol. (2010)